about
sameAs
β1 and β4 integrins: from breast development to clinical practiceHuman Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune responseThe cooperation between hMena overexpression and HER2 signalling in breast cancerIdentification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo.Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer.Molecular cloning of hMena (ENAH) and its splice variant hMena+11a: epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines.Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors.Human Mena+11a isoform serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cancer cell lineshMENA(11a), a hMENA isoform sending survival signals.The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome.Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasisMolecular and genetic bases of pancreatic cancer.hMENA(11a) contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells.Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting.Polyclonal Antibodies Against gp185HER2 Peptides: Their Putative Role in the Identification of a Particular HER2 Status in Patients With Breast Cancer.The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal receptor-negative tumors.Epitope mapping of the monoclonal antibody MM12.10 to external MDR1 P-glycoprotein domain by synthetic peptide scanning and phage display technologies.Thermosensitization, heat shock protein synthesis and development of thermotolerance in M-14 human tumor cells subjected to step-down heatingInterferon-gamma (IFN-gamma) can counteract the in vitro inhibitory effect of an HIV p24 immunosuppressive heptapeptideHost immunosurveillance contributes to the control of erbB-2 overexpression in HLA-A2-breast-cancer patientsSelective 'in synthesis' labelling of peptides by fluorochromesInfluence of both TCR repertoire and severity of the atopic status on the cytokine secretion profile of Parietaria officinalis-specific T cells
P50
Q27000311-034C4933-718D-4B2D-9C4F-506895B56CAFQ28251022-DF47454E-929D-46C9-9730-24C280BF95BDQ33786779-A268526C-AC52-4210-974C-DF7BCD30557CQ34592450-10AB17EB-E6F8-4D87-A2B4-45C13EF70B2CQ34957141-FB447F05-7878-4965-90C1-64BF7462F806Q35165997-D63C52DF-BC3D-4336-A5B7-D960C8D75863Q36436933-B6775D9C-3871-48B3-9AF3-C9D377F96C9FQ36982771-9C7C5845-98FC-4C79-BF37-624DFA206F57Q36998423-8BEE2914-9188-4FF4-BC23-ECF95E694148Q37557707-D73E25B6-9E14-4028-9E29-5B4BA1E3BCC7Q37586634-62E853E6-C0F0-4A6E-A799-1C9B654592DCQ37998095-02C6B213-FDB9-4E64-B0B0-A7892D971F8CQ38876630-E9588D37-F920-4128-BAE4-9D05E8F8E275Q39360312-7B2D4370-4B58-4CFA-B416-95E97481FC4CQ40800644-4F9400FE-B863-4651-84D1-415875AC5761Q46988395-CFAF7C52-A92C-431A-9E3F-83A680F4247DQ54090639-321A6316-D4B3-4ECF-87A1-2B75EE6764DBQ67584259-16B2DBC1-1CD5-46CC-863C-DE407F4C430CQ71537224-5E1B8FE4-62FD-410A-911C-7DD90A2D6454Q73196765-F0A1B15D-EEFD-4DDC-9899-EE75C56D02DCQ73626541-AAC09DF0-7DC3-401F-AB84-F4BED10505FFQ74251626-2F939178-2B7E-41D8-B1AF-AF47E299007B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francesca Di Modugno
@ast
Francesca Di Modugno
@en
Francesca Di Modugno
@es
Francesca Di Modugno
@nl
Francesca Di Modugno
@sl
type
label
Francesca Di Modugno
@ast
Francesca Di Modugno
@en
Francesca Di Modugno
@es
Francesca Di Modugno
@nl
Francesca Di Modugno
@sl
prefLabel
Francesca Di Modugno
@ast
Francesca Di Modugno
@en
Francesca Di Modugno
@es
Francesca Di Modugno
@nl
Francesca Di Modugno
@sl
P106
P21
P31
P496
0000-0003-1427-1883
P569
2000-01-01T00:00:00Z